SEC FORM 4
$1,416,000.00
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Sale of 300,000 shares at $4.72 per share.
Reporting Person Wai Conrad · Officer Title CEO, Counterpart Health · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001971702-26-000017 · filed 2026-09-16 · View filing →